A B S T R A C T Human, rat, and mouse placentas and rat and mouse intestines were homogenized in buffered saline, and a fraction consisting primarily of cell membranes was separated from each of the homogenates by differential centrifugation. Human, bovine, and guinea pig IgG, and human IgE, Bence-Jones protein, serum albumin, insulin, and growth hormone were labeled with "LUi or "HI, and the binding of these proteins by the cell membrane fractions was investigated. Rat and mouse sucklings were given labeled proteins intragastrically, and the amount of each protein absorbed after a given interval of time was determined. It was found that the degree and specificity of protein binding by the cell membrane fractions from human and murine placentas strikingly paralleled the relative rate and specificity of protein transport from mother to fetus in the respective species at or near term. Similarly, the degree and specificity of protein binding by the cell membrane fractions from suckling rat and mouse intestines tended to parallel the rate and specificity of protein absorption from the gastrointestinal tract in these animals. However, some discordance between protein binding and protein transport was also observed. The data suggest that: (a) the binding of a protein by specific receptors on cell membranes may be a necessary first step in the transcellular transport of the protein; (b) specific protein binding by cell receptors does not ensure the transport of that protein across the tissue barrier; and (c) specific transport mechanisms other than or in addition to specific cell membrane receptors are involved in the active transport of proteins across the human or murine placenta or the suckling murine intestine.
INTRODUCTION
The survival of most, if not all, mammalian species is dependent in part upon the successful transfer of maternal IgG from the mother to her offspring. This transference may occur either prenatally via the placenta as in primates (1) (2) (3) , both prenatally via the placenta and postnatally during the neonatal period via the intestinal tract (4, 5) as in the rat and mouse, or primarily postnatally as in the pig and cow (6, 7) . Although other maternal plasma proteins such as serum albumin and transferrin also traverse the primate and murine placentas and the proximal intestine of the murine suckling, these proteins do so much less readily than does IgG. Brambell (8) has suggested that the selective passage of IgG across these tissue barriers may be attributable to a preferential binding of IgG to hypothetical receptors present on the inner surface of the membrane which limits the pinocytotic vesicle: proteins in the external environment are brought into the cell by pinocytosis, and some are then presumed to be bound selectively by these receptors. The hypothesis requires that the receptors protect bound protein from intracellular digestion, whereas unbound protein is catabolized. Thus, proteins which are membrane bound would survive transit through the cell, and the amount of specific protein transferred across the tissue would be proportional to the degree of binding. Brambell (8) considered that the pinocytotic membrane might be either an extension or a derivative of the cell membrane and suggested that such receptors might also be present on the membrane of the microvilli. This concept of protein transport has recently received strong support from the observation by Jones and Waldmann (9) that cell membranes prepared from the intestines of suckling rats do indeed bind IgG preferentially over other plasma proteins.
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In the study reported here, the selectivity of protein binding in vitro by cell membrane fractions prepared from human, rat, and mouse placentas and from suckling rat and mouse proximal (10, 11) small intestine was compared to the transport of the same or related proteins across these tissues in vivo.
METHODS
Tissues and cell memibrane fractions. Fractions rich in cell membranes were prepared from homogenates of the following tissues: human placentas and fetal membranes obtained at term by hysterotokotomy, human placentas obtained at 7-8 wk of gestation by vaginal dilatation and forceps extraction, erythrocytes from venous blood of normal pregnant women at term, rat and mouse placentas and fetal membranes obtained at or near term, the liver and the proximal third of the small intestines from suckling rats 6-9 days of age and from suckling mice 5-8 days of age and 19 days of age, and the proximal third of the small intestines from adult mice and rats. The rats and mice were albino strains, the rats being descendants of a Wistar strain and the mice of a Swiss-Webster strain.
The cell membrane fractions were obtained by differential centrifugation using a modification of the method of Jones and Waldmann (9) . The tissues were homogenized in a cold 5 mM EDTA at pH 6.5 with a Waring blender, using 10-20 ml of buffer per g wet weight of tissue. The homogenate was centrifuged at 500 g for 10 min at 2°C, and the supernate was carefully collected, avoiding both the uppermost layer and the sediment. The supernate was again centrifuged at 500 g for 10 min, collected, and then centrifuged at 60,000 g for 20-30 min at 20C in polyallomer tubes using the fixed angle, type 40 rotor of a Spinco Model L preparative ultracentrifuge (Beckman Instruments, Inc., Spinco Div., Palo Alto, Calif.). The sediment or pellet obtained in each tube represented from 0.5 to 0.7 g of wet tissue; the pellets were washed twice with cold 0.1 M NaCl in 5 mM EDTA buffer of pH 6.5 at 60,000 g for 20 min. The washed pellets appeared to consist almost entirely of cell membranes when examined with the electron microscope. However, since small amounts of debris from other cell structures were also observed, this fraction will be referred to as the "60,000-g fraction."
Only the villous portion of the placenta was used for the human placental homogenates. The whole placenta stripped of fetal membranes was used for the rat and mouse placental homogenates. A given homogenate of human placenta or fetal membranes contained the tissue from a single conceptus, whereas a given homogenate of murine placenta or fetal membranes represented the pooled tissue from 20 to 36 conceptuses. A given homogenate of murine intestines or liver contained the respective pooled tissue from 22 to 79 sucklings or from 3 to 6 adults. A given human erythrocyte homogenate represented the cells from a single individual. Radiolabeled proteins. Crystallized human albumin (HA) ' was obtained from pooled adult plasma by the low temperature ethanol-water fractionation method of Cohn, Hughes, and Weare (12) . With columns of DEAE-cellu-'Abbreviations used in this paper: B-IgG, bovine IgG; BJX, Bence-Jones protein X-chain; F/M, fetal to maternal serum concentration ratio; GP-IgG, guinea pig IgG; HA, human albumin; HGH, human growth hormone; HI, human insulin; H-IgE, human IgE; H-IgG, human IgG. lose (13) , Bence-Jones protein (BJX) consisting of light chains (X-chains) was isolated from the urine of a myeloma patient; the amount of human IgG and/or y-chain present in the preparation expressed as IgG was 0.1%S as determined by radial immunodiffusion (14) using a rabbit antiserum specific for human ey-chain and using purified human IgG as the reference standard. With columns of DEAE-cellulose (13), human, bovine, and guinea pig IgG (H-IgG, B-IgG, and GP-IgG, respectively) were isolated from the appropriate normal serum. Human IgE (H-IgE) was separated from the plasma of a patient with IgE myeloma (15) using Sephadex G-200 (Pharmacia Fine Chemicals, Uppsala, Sweden) (16) followed by zone electrophoresis of the partially purified IgE preparation on Geon (B. F. Goodrich, Chemical Co., Avon Lake, Ohio) in 0.1 M borate buffer, pH 8.6 (17) . Crystallized human insulin (HI) was kindly provided by Dr. J. Schlichtkrull of the Novo Terapeutisk Laboratorium, Copenhagen, Denmark. The preparation of human growth hormone (HGH) used was obtained from the National Pituitary Agency, Baltimore, Md., through Dr. Frederic M. Kenny.
Aliquots of each of these proteins were labeled with "31I, and additional aliquots were labeled with 'MI. The radioiodination method used was a modification of the nitrous acid method of Pressman and Eisen (18) as has been described elsewhere (19) . Each of the radiolabeled proteins contained less than 0.5 atoms of iodine per protein molecule.
Over 98%c of the total radioactivity in each of these protein preparations was precipitable in 10% TCA, and from 92 to 97%o of the radioactivity was precipitable immunochemically using specific antisera.
Assay of protein binding to the 60,00-Xg fraction. Aliquots of each of the radiolabeled proteins containing from 3 to 8 ,ug of labeled protein with 0.05-0.2 ,tCi of radioactivity were added either to: (a) duplicate or triplicate 10-ml aliquots of supernate obtained after the second centrifugation of the tissue homogenate at 500 g, or (b) duplicate or triplicate tubes containing the washed 60,000-g fraction resuspended in 5 mM EDTA at pH 6.5, or (c) both. It should be noted that the aliquots of supernate were placed in the polyallomer tubes used (Beckman Instruments, Inc., Spinco Div.) before the addition of labeled protein. When the washed 60,000-g fraction was used, the fraction was resuspended in the same polyallomer tube in which it had been isolated from a 10-ml aliquot of the 500-g supernate, and then the labeled protein was added. In no instance was radiolabeled protein added to a polyallomer tube which did not or had not contained the 500-g supernate of a tissue homogenate. All subsequent operations were carried out in the same polyallomer tube. Although the amount of a given labeled protein added varied from 3 to 8 ,ug, differences in the amount of protein bound attributable to this degree of variation were not detected. The mixtures were incubated for 1-3 h at 37°C; incubation beyond 1 h had little apparent effect on the amount of labeled protein which was bound to the 60,000-g fraction. After centrifugation at 60,000 g for 20-30 min in the type 40 rotor, the supernates were collected, and the pellets were washed twice with 10 ml of 0.1 M NaCl in 5 mM EDTA at pH 6.5 (9) . The washed pellets and aliquots of the initial supernates were assayed for radioactivity, and the percentage of the total radioactivity in the mixture that was bound to the washed 60,000-g fraction was determined. When a given radiolabeled protein was mixed with 500-g tissue supernate, the percentage bound to the resulting 60,000-g fraction was the same as that obtained when the protein was mixed instead directly with the washed 60,000-g fraction. Binding of the labeled proteins to the pollyallomer tubes containing the pellets was determined by washing the pellets from the tubes with the EDTA buffer and then assaying the empty tubes for radioactivity; in no instance was this apparent binding greater than 5% of the radioactivity present in the pellet. Assay of radioactivity was performed using a 2-or 3-inch NaI crystal, each in conjunction with scalers capable of discriminating between "31I and "JI.
Inhibition of labeled protein binding with specific imelabeled proteins. The effect of protein concentration on binding was investigated by mixing a given radiolabeled protein with various amounts of the same or different purified unlabeled proteins. These mixtures were then added to aliquots of resuspended washed 60,000-g fractions, incubated at 370C, and centrifuged at 60,000 g for 20-30 min in the type 40 rotor. The pellets were then washed twice with 10 ml of 0.1 M NaCl in 5 mM EDTA at pH 6.5. Both the initial supernate and the washed pellets were assayed for radioactivity.
Gastrointestinal absorption of labeled proteins by suckling rats and mice. Pregnant rats and mice near term were placed on drinking water containing 50 mg of NaI and 5 g of sucrose per 100 ml, and the animals were kept on this solution after delivery of their young. When the suckling rats and mice were 6-11 days old and 8-10 days old, respectively, they were weighed, and were then given an "M1labeled protein and an "MJ-labeled protein together intragastrically via a soft polyethylene catheter, 0.024 inches in outside diameter and having a 0.01-inch bore, passed into the stomach per os. Since the scalers and detectors used for radioactivity assay permitted easy differentiation between "31I and 'I, the absorption of two different proteins in the same animal could be estimated. Different amounts of either unlabeled H-IgG or HA were added to the radiolabeled protein mixture before intragastric instillation, so that the amount of H-IgG given varied from mixtures were given in a volume of 0.3 ml per rat and 0.1 ml per mouse; a given mixture was given to six suckling rats and six to eight suckling mice. Half of each group was killed with ether anesthesia at 5 or 7 h after administration of the labeled proteins, and the other half was killed at 24 or 25 h. The entire gastrointestinal tract of each animal was removed immediately after the animal's death, and the carcasses were homogenized in 20% TCA using a Waring blender at high speed. After decanting, the blender was washed twice with 20%o TCA, and the total volume of the homogenate including the washings was adjusted to 200 ml with 20% TCA. In the case of the suckling rats, each carcass was homogenized separately; in the case of the mice, the carcasses of the three or four mice comprising each group were homogenized together. The precipitates from duplicate 10-ml aliquots of each homogenate were collected by centrifugation, washed twice with 10%o TCA, and then assayed for both 1I and 'MI. Since some of the protein absorbed by the suckling was present in the blood and interstitial fluids removed with the gastrointestinal tract, the amount of labeled protein found in the carcass was considered as the minimum amount of protein absorbed.
Additional suckling rats and mice were given an inj ection of either unlabeled H-IgG or unlabeled HA subcutaneously 7.5 h before the intragastric instillation of the labeled protein mixture. The amount of H-IgG injected ranged from 2.4 to 9.5 mg/g of body wt in the rats and from 3.1 to 9.3 mg/g of body wt in the mice. The volume of distribution (19) of H-IgG in the murine suckling is approximately 20% of the body weight; the maximum serum levels of H-IgG achieved after distribution of the H-IgG in the body were calculated (19) to be from approximately 1,200 to 4,700 mg/100 ml in the rat and from 1,500 to 4,600 mg/100 ml in the mouse. The amount of HA injected was from 7.4 to 14.9 mg/g of body wt in the rat and from 4.8 to 6.0 mg/g of body wt in the mouse; the serum levels of HA reached after distribution were calculated to be about 3,700-6,400 mg/100 ml in the rat and from 2,400 to 3,000 mg/100 ml in the mouse. Subcutaneously injected H-IgG and HA reach a steady-state distribution between plasma and interstitial fluids (19) within 2-4 h in the rat and mouse. The intragastric dose of labeled protein contained less than 2.4 ,ug of labeled H-IgG and less than 40 ,ug of labeled HA. The animals were killed 23 h after the intragastric administration of labeled protein, and the carcasses, less the gastrointestinal tract, were assayed for TCA-precipitable radioactivity.
In some experiments, the concentrations of labeled protein in the sera of the sucklings after absorption, instead of in the carcasses, were determined. In these instances, the serum obtained from each of four rats in a given group was pooled as was the serum from each of six mice in a group, and aliquots of the pooled sera were assayed for TCA-precipitable radioactivity.
To determine if the labeled H-IgG absorbed via the gastrointestinal tract may have been drastically modified during the absorptive process, approximately 20 GCi of 3JI-labeled H-IgG were given to 8-day-old suckling mice either intragastrically or subcutaneously. Sera obtained 24 h later were injected intravenously into adult mice which were then counted daily in a whole body counter devised from a 2-inch NaI crystal probe coupled to a Picker scaler (Picker Briggs Corp., Cleveland, Ohio) with a pulse height discriminator. Other adult mice were given the labeled protein directly without prior passage through suckling mice. In this way, the half-life of the serum radioactivity found in the suckling mice which had been given labeled H-IgG intragastrically was compared with the half-life of the labeled H-IgG present in the serum of suckling mice which had been given the protein subcutaneously.
RESULTS
Protein binding to humtan placenta and fetal membranes. The binding of each of the radiolabeled proteins studied to the 60,000-g fraction from term human placenta is given in Table I in order of decreasing degree. As will be noted, BJX was bound the most; approximately 10% of the radiolabeled BJX added to the tissue homogenate fractions was fixed by the 60,000-g fraction.
On the other hand, less than 0.5% of radiolabeled HA was found to be bound. The binding of HI, which was the second most bound protein, averaged 8.3 times that of HGH. Of the immunoglobulins investigated, H-IgG binding was slightly greater than that of GP-IgG and more than 3 times that of either B-IgG or H-IgE. For those proteins studied, binding by the 60,000-g fraction from placentas of 7-8-wk gestation was virtually the same as the binding obtained with term placentas (Table I ). In the case of the 60,000-g fraction from fetal membranes, when the proteins studied were listed in order of their degree of binding, the order was the same as that obtained with the placenta, but the absolute binding of B-IgG, at least, appeared to be somewhat different from that for the placenta (Table I) . Protein binding to the 60,000-g fraction from human erythrocytes was different, both in relative terms and in absolute terms, from protein binding obtained with either the placenta or the fetal membranes (Table I) .
When unlabeled H-IgG was added to radiolabeled H-IgG and the mixture was then added to suspensions of washed 60,000-g fractions from term placentas, the percentage of labeled H-IgG bound to the fraction was markedly affected (Fig. 1) . At a total H-IgG concentration in the suspension of only 0.2 mg/ml, H-IgG binding was 2.1%, or about one-third of that obtained without the addition of unlabeled H-IgG. At a concentration of 1.0 mg of H-IgG/ml of suspension, H-IgG binding was 1.5%, and at an H-IgG concentration of 20 mg/ml, the binding was about 1.1% (Fig. 1) . When unlabeled H-IgG was added to radioiodinated BJx, a similar decrease, albeit relatively less marked, in the percentage of BJX bound to the placental 60,000-g fraction was observed (Fig. 1) . Unlabeled H-IgG inhibited the binding of B-IgG to the same relative degree as it did the binding of labeled H-IgG. The concentration of H-IgG appeared to have little or no effect on the binding of radiolabeled HA (Fig. 1) . Conversely, unlabeled HA in concentrations up to and including 20 mg/ml, had no obvious effect on the binding of either H-IgG or BJX. Although increasing amounts of unlabeled HA consistently decreased the amount of labeled albumin bound, from a mean of 0.40% without added albumin to 0.24% at a concentration of 20 mg HA/ml (Fig. 1) , the difference between the means was not significant. Unfortunately, the amount of BJX available was insufficient to permit an assessment of the effect of unlabeled BJX on the binding of the labeled proteins.
The data in Fig. 1 also indicate that as the concentration of specific protein in the suspension increased, the amount of that protein which was bound by the 60,000-g fraction of term placenta actually increased, despite the fact that the percentage bound decreased. For example, it can be calculated from Fig. 1 that the amount of H-IgG bound at 1.0 mg/ml averaged 0.15 mg, or 1.5% of 1.0 mg/ml in a total volume of 10 ml; at a concentration of 10 mg/ml, the amount of H-IgG bound was calculated to average 1.24 mg, and at 20 mg/ml, the amount bound was 2.2 mg (Fig. 3) . Protein binding to placenta and fetal membranes of rats and mice. The binding of labeled BJX, H-IgG, B-IgG, and HA to the 60,000-g fraction from term placentas of both rats, and mice was similar to that found for the human term placenta (Table II) , although the binding of labeled HI seemed to be somewhat greater (Table II) . The 60,000-g fraction from murine fetal membranes bound H-IgG and B-IgG to a degree similar to that seen for the murine placenta (Table II) .
Protein binding to rat and mouse intestinal fractions. In sharp contrast to the binding of H-IgG to human, rat, or mouse 60,000-g placental fractions, the 60,000-g fraction from suckling rat, and mouse intestines bound approximately 50% of the labeled H-IgG (Table III) . Although bound to a lesser degree than H-IgG, the binding of B-IgG to suckling murine intestines (Table  III) was also at least fivefold greater than its binding to any of the placental 60,000-g fractions studied. On the other hand, the binding of HI and BJX to the sucklng intestinal fraction was approximately the same as or less than the binding of these proteins to the murine placental 60,000-g fractions. The degree of H-IgG binding to the 60,000-g intestinal fraction from adult rats and mice (Table III) was considerably lower than that for the suckling intestinal fraction, whereas the reverse was true for HI and BJX. The binding of labeled pro- (Fig. 2) . Even the 60,000-g fraction from suckling mouse liver appeared to be H-IgG concentration dependent in terms of the percentage of labeled H-IgG bound (Fig. 2) . The concentration of HA in the incubation mixtures, at least up to 20 mg of HA/ml of suspended 60,000-g fraction, had no apparent effect on the H-IgG binding by any of the mouse tissues. The binding of labeled H-IgG and labeled B-IgG by the 60,000-g fraction from intestines of 6-9-day-old rats was likewise sensitive to the total H-IgG concentration (Fig. 2) . The binding of BJX by intestinal 60,000-g fractions from suckling rats was dependent upon the H-IgG concentration, but much less so than was H-IgG or B-IgG binding (Fig. 2) . The concentration of HA had no obvious effect on the binding of H-IgG, B-IgG, or BJX by rat suckling intestines. As with the human placental 60,000-g fractions, the amount of H-IgG bound by rat and mouse intestinal 60,000-g fractions appeared to increase when the concentration of H-IgG was increased, despite the fact that the percentage of the total H-IgG bound decreased (Fig. 3) .
Absorption of labeled proteins in suckling rats and mice after intragastric instillation. The amounts of H-IgG found in the carcass of the 6-11-day-old suckling rat at 7 and at 25 h after different amounts of H-IgG were given intragastrically are shown in Fig. 3 . It may be noted that as the amount of H-IgG administered was increased, the amount of H-IgG absorbed by 25 Oral protein-mg/g 10l the intragastric dose was increased; there was no evident plateau for the amount of H-IgG absorbed at doses up to and including 3.03 mg/g of body wt (Fig. 3) . H-IgG-mg suckling mouse increased as the dose increased, the highest dose given in this case being 1.92 mg/g body wt (Fig. 3 ).
The percentage of the H-IgG dose that was absorbed was H-IgG dose dependent in both the rat and the mouse. As the dose of H-IgG in the rat was increased from the lowest dose studied, 0.22 /g/g of body wt, to 0.17 mg/g of body wt, the percentage of the H-IgG dose that was absorbed decreased dramatically (Fig. 2) . Similarly, as the intragastric H-IgG dose was increased in the mouse from 0.25 jeg/g, the smallest dose given, to 0.20 mg/g, the percentage of the H-IgG dose that was absorbed fell precipitously (Fig. 2) . When unlabeled HA was substituted for unlabeled H-IgG in the intragastric dose, the percentage of the tracer dose of labeled H-IgG that was absorbed either remained unchanged or increased slightly over an HA dose range from 40 Ag to 3.5 mg/g of body wt.
The amount of HA absorbed after intragastric administration was much less than the amount of H-IgG absorbed at equivalent doses of specific protein (Fig. 3) . Loading the suckling intragastrically with amounts of unlabeled H-IgG up to 3.0 mg/g of body wt given together with labeled HA had no apparent effect on the absorption of labeled HA.
In the rat suckling, the subcutaneous administration of unlabeled H-IgG in amounts up to 9.5 mg/g of body wt given 7.5 h before the intragastric instillation of labeled H-IgG had little or no effect on the amount of H-IgG absorbed. Similarly, the administration of unlabeled H-IgG subcutaneously in the mouse suckling in amounts up to 9.2 mg/g of body wt had little apparent effect on the absorption of H-IgG given intragastrically. The serum concentrations of labeled H-IgG, B-IgG, and HA which were found 21 h after intragastric administration in suckling rats and mice are given in Table IV, expressed as a percentage of the intragastric dose per milliliter of serum. The serum concentration of BJX was estimated 5 h after intragastric administration instead of 21 h, because of the relatively short halflife of BJX in the serum of these animals, i.e., approximately 11 h. As a reference for the BJX serum levels, the serum concentration attained by H-IgG at 5 h after intragastric instillation was also determined (Table IV) . It will be noted that relatively little BJX was absorbed via the gastrointestinal tract in either rats or mice; even assuming instantaneous absorption, the short half-life of BJX cannot alone explain the relatively low serum concentrations found, since the maximum serum levels then attained would still be only about 8 times those observed.
An increase in the amount of H-IgG placed in the stomach of the suckling animal resulted in a decrease in the percentage of the H-IgG dose which was found in the serum: administration of only 1.5 mg of H-IgG/g of body wt resulted in a serum H-IgG level of only 1.65% of the intragastric dose per ml of serum in the rat and only 4.12% of the dose per ml of serum in the mouse. Similarly, 1.5 mg of either H-IgG or B-IgG depressed the absorption of B-IgG, the amount of B-IgG found per milliliter of serum being less than 1% of the intragastric dose.
The radioactivity which was present in the serum of suckling mice after the intragastric instillation of labeled H-IgG had a half-life of 5.5 days in adult mice after intravenous injection. The radioactivity found in the serum of suckling mice given labeled H-IgG subcutaneously also had a half-life of 5.5 days in adult mice after intravenous injection. In both cases, the radiolabeled protein disappeared from the adult mice with a single exponential, and the disappearance curves were indistinguishable from each other. The half-life of labeled H-IgG injected intravenously into adult mice directly without being passed through suckling mice had a half-life of 5.5 days. Thus, labeled H-IgG did not appear to be drastically altered during its passage across the mouse suckling intestine.
DISCUSSION
When labeled H-IgG and labeled HA are given to the normal pregnant woman at term, the concentrations of these proteins in the serum of the fetus 1 day later are 0.07 and 0.006 times, respectively, their concentrations in maternal serum (3) . Thus, both H-IgG and HA traverse the human term placenta in the direction of mother to fetus but at different net rates: the fetal to maternal serum concentration ratio, F/M, for labeled HA at 1 day after injection into the mother is only 8.6% of the F/M ratio for labeled H-IgG (Table V) . It can be seen from the data in Table I that the binding of HA to the 60,000-g fraction from human term placenta is 6.6% of the binding of H-IgG (Table V) , corresponding closely with the relative F/M ratios for these two proteins. A similar qualitative correspondence between maternofetal transfer and placental binding is apparent for BJ: immunoglobulin light chains isolated from normal human urine are, of course, BJ, and the F/M ratio for these chains in the pregnant women at term (3) 1 day after injection is 0.25, or approximately 3.6 times that for H-IgG (Table V) ; the binding of BJX to the 60,000-g fraction from human term placenta (Table I) is 1.7 times that for R-IgG (Table V) . Thus, the relative net transplacental transfer rates of H-IgG, BJX, and HA in the pregnant women at term approximate the relative binding of these proteins to the cell membrane fraction from the human term placenta. Similarly, the relative net maternofetal transfer rates for H-IgG, B-IgG, and HA in the rat (20) and for H-IgG and BJX in the mouse (20) correlate qualitatively with the relative binding of these proteins to the respective 60,000-g placental fractions (Table V) . In addition, protein specificity in maternofetal transport is similar (Table V) , whereas HA does (22) . Similarly, B-IgG is bound to the mouse placental 60,000-g fraction at least half as wvell as H-IgG, but passes from mother to fetus in the mouse (Table V) of the administered dose, respectively, 4 h after the proteins were placed in the intestinal lumen. Binding of labeled H-IgG, B-IgG, H-IgE, and HA in vitro to the 60,000-g fraction from suckling rat intestine averaged 54.1%, 17.6%, 13.6% and 2.3%, respectively. The binding of labeled proteins by the 60,000-g fraction from suckling murine intestine is greater than binding by the analogous fraction from placenta. In fact, the binding of H-IgG by the suckling rat and mouse intestinal fraction is 8-12 times, respectively, that by the corresponding placental fraction. Similarly, the transfer of IgG from mother to the offspring in the rat and mouse seems to be more effective via the intestine than via the placenta (31): the concentration of IgG in the murine neonate is only a small fraction of that in the mother, but it rapidly reaches the maternal concentration after a few days of suckling without a concomitant increase in neonatal endogenous IgG synthesis. Superficially, at least, the in vitro binding of immunoglobulins to suckling murine intestine as compared to the binding of immunoglobulins by murine placenta is in accord with Brambell's suggestion that specific receptors are important for protein transport.
Intestinal absorption of intact proteins in the rat and mouse seems to be related to protein binding in vitro in still other ways. The total amount of H-IgG bound by the 60,000-g fraction from suckling mouse intestine and the total amount of H-IgG absorbed in the mouse both increase as the amount of H-IgG in the system increases, at least up to levels of 20 mg H-IgG/ml in vitro and 22.5 mg H-IgG/animal in vivo. On the other hand, as the amount of H-IgG added to the 60000-g fraction from suckling rat intestine increases, the total amount of H-IgG bound falls rapidly below that for the suckling mouse intestine at equivalent amounts of H-IgG in the system. This may be related to the observation that the total amount of H-IgG absorbed in the rat is readily saturated at doses of H-IgG which do not saturate the intestinal H-IgG transport system in the mouse. In the rat and in the mouse, both absorption and binding of labeled H-IgG seem to be specific, since the percentage of labeled H-IgG that is bound is easily inhibitable with unlabeled H-IgG but not with unlabeled HA.
The observation that the relative serum concentrations of B-IgG and HA after administration to both rat and mouse approximate the relative binding of these proteins in vitro (Table IV) is still additional support for the receptor theory of protein transport. Interestingly, the amount of specific protein in the serum of the suckling is without effect on the amount of that protein absorbed, a fact which also can be interpreted as favoring the receptor theory.
In contrast to the increased maternofetal transport of H-IgG by the human or murine placenta as term approaches, murine absorption of intact H-IgG via the intestine is curtailed when the animal is 19-21 days of age, and little such absorption occurs in the adult ani-
